Author:
Hirschfeld Marc,Ouyang Yi Qin,Jaeger Markus,Erbes Thalia,Orlowska-Volk Marzenna,zur Hausen Axel,Stickeler Elmar
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference38 articles.
1. Stanojevic Z, Djordjevic B, Todorovska I, Lilic V, Zivadinovic R, Dunjic O. Risk factors and adjuvant chemotherapy in the treatment of endometrial cancer. J BUON. 2008;13(1):23–30.
2. Ryan AJ, Susil B, Jobling TW, Oehler MK. Endometrial cancer. Cell Tissue Res. 2005;322(1):53–61.
3. Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res. 2013;25(1):46–54.
4. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–7.
5. Shabani N, Kuhn C, Kunze S, Schulze S, Mayr D, Dian D, et al. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer. 2007;43(16):2434–44.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献